Showing 1 - 6 of 6
Liver cancer detection system from Japan to debut
News, Post Reporters, Published on 09/06/2022
» A world-leading system developed in Japan to detect liver cancer is to be introduced in Thailand, where the disease is a major health issue.
GPO cleared to make its own Favipiravir tablets
News, Post Reporters, Published on 07/05/2021
» The path has been cleared for the Government Pharmaceutical Organization (GPO) to produce one million tablets a month of the antiviral medicine Favipiravir after the Department of Intellectual Property (DIP) rejected a request by a company to patent the drug here.
DIP rejects bid to patent Covid treatment
News, Phusadee Arunmas and Supoj Wancharoen, Published on 06/05/2021
» The Department of Intellectual Property (DIP) has rejected a request to patent the anti-viral drug Favipiravir which is being administered to patients with few if any Covid-19 symptoms.
Govt has plenty of favipiravir
News, Mongkol Bangprapa, Published on 04/05/2021
» The government said on Monday it had secured a plentiful supply of favipiravir, a vital drug in the fight against Covid-19, and was urgently seeking permission to manufacture it itself.
Time limit put on drug patent
News, Phusadee Arunmas and Apinya Wipatayotin, Published on 01/05/2021
» The Department of Intellectual Property (DIP) can reject a Japanese firm's bid to patent favipiravir -- the antiviral medicine used as a treatment for Covid-19 -- in Thailand if it fails to provide information on its new innovation by August.
TCC urges govt to support local antiviral drug production
News, Post Reporters, Published on 29/04/2021
» The Thailand Consumers Council (TCC) yesterday called on the government to support the Government Pharmaceutical Organisation (GPO) make its own favipiravir -- the antiviral medicine used as a treatment for Covid-19.